JP MORGAN PARTNERS BHCA LP's Net Worth
$2.24 Billion
Who is JP MORGAN PARTNERS BHCA LP?
JP MORGAN PARTNERS BHCA LP has an estimated net worth of $2.24 Billion. This is based on reported shares across multiple companies, which include CORGENTECH INC, SANTARUS INC, 1 800 FLOWERS COM INC, HOME PRODUCTS INTERNATIONAL INC, COMSCORE, INC., ICAGEN INC, MYOGEN INC, SEATTLE GENETICS INC /WA, PHARMOS CORP, EYETECH PHARMACEUTICALS INC, BARRIER THERAPEUTICS INC, PortalPlayer, Inc., JP MORGAN PARTNERS BHCA LP, BILL BARRETT CORP, CMGI INC, WARNER CHILCOTT PLC, NUCO2 INC /FL, ENCORE ACQUISITION CO, ARAMARK Holdings Corp, Emergent BioSolutions Inc., HANGER ORTHOPEDIC GROUP INC, Kraton Performance Polymers, Inc., Warner Chilcott Ltd, CANDLEWOOD HOTEL CO INC, ARAMARK CORP, ARAMARK CORP/DE, PLIANT CORP, CROWN MEDIA HOLDINGS INC, and GUITAR CENTER INC.
SEC CIK
JP MORGAN PARTNERS BHCA LP's CIK is 0001106607
Past Insider Trading and Trends
2004 was JP MORGAN PARTNERS BHCA LP's most active year for acquiring shares with 28 total transactions. JP MORGAN PARTNERS BHCA LP's most active month to acquire stocks was the month of July. 2004 was JP MORGAN PARTNERS BHCA LP's most active year for disposing of shares, totalling 71 transactions. JP MORGAN PARTNERS BHCA LP's most active month to dispose stocks was the month of July. 2004 saw JP MORGAN PARTNERS BHCA LP paying a total of $8,333,324.00 for 17,521,508 shares, this is the most they've acquired in one year. In 2015 JP MORGAN PARTNERS BHCA LP cashed out on 26,532,756 shares for a total of $824,329,338.96, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
SEATTLE GENETICS INC /WA (SGEN) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.20% | -21.50K |
$10.36 | -$222,740.00 | 1.77M |
Jul 25 - Jul 28
| |||
Form 4
| -7.94% | -150.00K |
$10.81 | -$1,621,500.00 | 1.74M |
Jul 25
| |||
Form 4
| -4.80% | -100.00K |
$10.14 | -$1,014,000.00 | 1.98M |
May 15
| |||
Form 4
| -5.57% | -122.89K |
$10.10 | -$1,241,219.30 | 2.08M |
May 14
| |||
Form 4
| -2.28% | -51.54K |
$10.06 | -$518,452.16 | 2.2M |
May 13
| |||
Form 4
| -0.93% | -21.22K |
$12.63 | -$268,059.12 | 2.26M |
Dec 10
| |||
Form 4/A
|
∞
| 4.49M |
—
|
—
| 4.49M |
Jul 9
| |||
Form 4
| +149,500.00% | 4.49M |
—
|
—
| 4.49M |
Feb 9 - Jul 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
| +0.05% | 270 |
$8.57 | -$17,266,236.10 | 522.22K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PHARMOS CORP No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EYETECH PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.92% | 43.75K |
$1.44 | $63,000.00 | 2.32M |
Nov 7
| |||
Form 4
| -100.00% | -2.32M |
—
|
—
|
0
|
Nov 14
| |||
Form 4
| +1.56% | 35K |
$0.01 | $350.00 | 2.28M |
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
| -30.86% | -1.00M |
$41.26 | -$41,260,000.00 | 2.24M |
Oct 28
| |||
Form 4/A
| +33.33% | 4.05M |
$7.00 | $3,333,326.00 | 16.2M |
Feb 4
| |||
Form 4
| -20.00% | -810.22K |
$38.50 | -$31,193,585.50 | 3.24M |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 12
| |||
Form 4
| +33.33% | 4.29M |
$7.00 | $4,999,998.00 | 17.16M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BARRIER THERAPEUTICS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.66M |
$4.15 | -$11,025,886.00 |
0
|
Aug 5 - Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| -16.37% | -491.43K |
$18.33 | -$9,007,966.89 | 2.51M |
Feb 15
| |||
Form 4
|
—
|
0
|
$7.94 |
—
| 2.47M |
Dec 30
| |||
Form 4
|
∞
| 3.15M |
—
|
—
| 3.15M |
Apr 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ANESIVA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +252.20% | 2.41M |
—
|
—
| 3.37M |
Dec 15 - Dec 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
$5.15 |
—
| 3.12M |
Dec 30
| |||
Form 4
| -15.36% | -694.44K |
$17.70 | -$12,291,658.80 | 3.83M |
Nov 17
| |||
Form 4
|
∞
| 4.52M |
—
|
—
| 4.52M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||